May 11, 2023

Press Release: Historic achievement for the ongoing InPACT penile cancer trialโ€”100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

March 8, 2023

The ComboMATCH patient registration trial and three treatment trials are now open

February 15, 2023

A participant in the E1910 trial shares her experience in a Penn Medicine feature story with her hematologist, Dr. Selina Luger

February 10, 2023

The January/February 2023 News from ECOG-ACRIN blog is now available

January 30, 2023

Now Enrolling: The BRIDGE research study is evaluating a new treatment approach for patients with early bladder cancer

December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

December 19, 2022

Blinatumomab Plus Consolidation Chemotherapy Significantly Reduces Risk of Death in MRD-Negative B-Cell ALL

December 15, 2022

Study E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)

December 14, 2022

Blinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)

ECOG-ACRIN Cancer Research Group